基于CiteSpace及VOSviewer的国内外糖尿病视网膜病变治疗的研究热点可视化分析

Visualized analysis of research hotspots of the treatment of diabetic retinopathy based on CiteSpace and VOSviewer

摘要:

目的：分析全球糖尿病视网膜病变治疗方式的研究现状、热点及趋势。

方法：检索中国知网(CNKI)和Web of Science核心合集数据库建库至2023-06-15关于糖尿病视网膜病变的相关研究，应用CiteSpace 6.2.R2及VOSviewer软件依次以国家/发文机构、研究作者、关键词等为分析节点进行可视化分析。

结果：纳入中文文献5 919篇，英文文献11 475篇。全球发文量位于前3位的国家分别为美国、中国和英国，国外前3位发文机构分别为哈佛医学院、哈佛大学及约翰斯·霍普金斯大学，国内前3位发文机构分别为中国中医科学院眼科分院、湖南中医药大学及中山大学中山眼科中心。中英文高频关键词及爆点关键词的分析结果显示，激光光凝术、玻璃体切除术、中医药疗法、血管内皮生长因子、雷珠单抗等为研究热点。

结论：近年糖尿病视网膜病变的研究热点主要以手术、血管保护剂、中医药疗法、抗血管内皮生长因子等为主，研究趋势以抗血管内皮生长因子药物为主。

Abstract:

AIM: To analyze the current status, hotspots and trends of studies on the treatments of diabetic retinopathy.

METHODS: Relevant literatures on diabetic retinopathy in Chinese National Knowledge Infrastructure(CNKI)and Web of Science core collection database were retrieved from creation to June 15, 2023, and CiteSpace 6.2.R2 and VOSviewer were used to conduct visualized analysis with the country/issuing institution, research author and keywords.

RESULTS: A total of 5 919 Chinese literatures and 11 475 English literatures were included. The top three countries with global publications are the United States, China and the United Kingdom, respectively. The top three institutions for issuing articles at abroad are Harvard Medical School, Harvard University and Johns Hopkins University, while the top three institutions for issuing articles in China are the Eye Hospital of China Academy of Chinese Medical Science, Hunan University of Chinese Medicine, and Zhongshan Ophthalmic Center of Sun Yat-sen University. The research results of high-frequency keywords in both Chinese and English show that the laser photocoagulation, vitrectomy, traditional Chinese medicine therapy, vascular endothelial growth factor and ranibizumab are research hotspots.

CONCLUSIONS: In recent years, the research hotspots of diabetic retinopathy mainly focus on surgery, vascular protective agents, traditional Chinese medicine therapy, anti-vascular endothelial growth factor, etc., and the research trend mainly focuses on anti-vascular endothelial growth factor drugs.